Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes

QR Code

Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes

João Coelho1, Luísa Malheiro1, João Melo Beirão1,2, Angelina Meireles1,2, Bernardete Pessoa1,2 1Unit of Ophthalmology, Centro Hospitalar Universitário Do Porto, Porto, Portugal; 2Unit of Ophthalmology, Universidade Do Porto-Instituto Ci&ecir...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Coelho J, Malheiro L, Melo Beirão J, Meireles A, Pessoa B
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2019
Sujets:	diabetic macular edema fluocinolone acetonide dexamethasone implant intravitreal implants real-world vitrectomy Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/7d332ae5de2a45b99615deb965cb1585
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Rapid Structural and Functional Improvements with the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Patients with DME and Low Visual Acuity: 6-Month Data from the UAE
par: Elbarky AM
Publié: (2020)

Ahmed glaucoma valve in uveitic patients with fluocinolone acetonide implant-induced glaucoma: 3-year follow-up
par: Kubaisi B, et autres
Publié: (2018)

Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study
par: Massin P, et autres
Publié: (2016)

Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis
par: Zarranz-Ventura J, et autres
Publié: (2020)

Comment on ’Effectiveness of 190 μg Fluocinolone Acetonide versus 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis’ [Response to Letter]
par: Zarranz-Ventura J, et autres
Publié: (2020)

Evaluating the Safety, Efficacy and Patient Acceptability of Intravitreal Fluocinolone Acetonide (0.2mcg/Day) Implant in the Treatment of Non-Infectious Uveitis Affecting the Posterior Segment
par: Steeples LR, et autres
Publié: (2021)

Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN®) and Follow-Up Considerations/Recommendations
par: Adán A, et autres
Publié: (2020)

Real-World Outcomes in Diabetic Macular Edema for the 0.2 μg/Day Fluocinolone Acetonide Implant: Case Series from the Midlands, UK
par: Mushtaq B, et autres
Publié: (2021)

Clinical utility of intravitreal fluocinolone acetonide (Iluvien®) implant in the management of patients with chronic diabetic macular edema: a review of the current literature
par: Saedon H, et autres
Publié: (2017)

Letter to the Editor Regarding the “Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The Constant Analysis” Article [Letter]
par: Taylor K, et autres
Publié: (2020)

Dexamethasone implant in the management of diabetic macular edema from clinician’s perspective
par: Urbančič M, et autres
Publié: (2019)

A Real-World Study of Dexamethasone Implant in Treatment-Naïve Patients with Diabetic Macular Edema: Efficacy and Correlation Between Inflammatory Biomarkers and Treatment Outcome
par: Vadalà M, et autres
Publié: (2020)

Update on corticosteroids for diabetic macular edema
par: Schwartz SG, et autres
Publié: (2016)

Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy
par: Wallsh J, et autres
Publié: (2016)

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea
par: Kim MS, et autres
Publié: (2021)

Effects of Repeated Intravitreal Injections of Dexamethasone Implants on Intraocular Pressure: A 4-Year Study
par: Pacella E, et autres
Publié: (2020)

Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex® Outcomes
par: Udaondo P, et autres
Publié: (2021)

Adding a Corticosteroid or Switching to Another Anti-VEGF in Insufficiently Responsive Wet Age-Related Macular Degeneration
par: Kaya C, et autres
Publié: (2019)

Guidelines for the Management of Center-Involving Diabetic Macular Edema: Treatment Options and Patient Monitorization
par: Figueira J, et autres
Publié: (2021)

Choroidal Blood Flow After Intravitreal Ranibizumab in Vitrectomized and Non-Vitrectomized Eyes with Diabetic Macular Edema
par: Pessoa B, et autres
Publié: (2021)

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
par: Hall J
Publié: (2016)

Usefulness of anti-vascular endothelial growth factor combined with dexamethasone implant for retinal vein occlusion
par: Kim M
Publié: (2016)

Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone
par: Zola M, et autres
Publié: (2017)

Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy
par: Cham A, et autres
Publié: (2016)

Comparison of Posterior Hyaloid Assessment Using Preoperative Optical Coherence Tomography and Intraoperative Triamcinolone Acetonide Staining During Vitrectomy
par: Albabtain B, et autres
Publié: (2021)

Macular edema resolution assessment with implantable dexamethasone in diabetic retinopathy (MERIT): a pilot study
par: Chhablani J, et autres
Publié: (2018)

Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series
par: Singer MA, et autres
Publié: (2016)

Dexamethasone 0.4mg Sustained-Release Intracanalicular Insert in the Management of Ocular Inflammation and Pain Following Ophthalmic Surgery: Design, Development and Place in Therapy
par: Brooks CC, et autres
Publié: (2020)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
par: Laine I, et autres
Publié: (2017)

Anti-inflammatory drug-eluting implant model system to prevent wear particle-induced periprosthetic osteolysis
par: Rivera MC, et autres
Publié: (2019)

Longstanding refractory pseudophakic cystoid macular edema resolved using intravitreal 0.7 mg dexamethasone implants
par: Brynskov T, et autres
Publié: (2013)

Is There a Difference in the Resonance Frequency Values Obtained Directly on the Implants and Abutments?
par: Pozzer,Leandro, et autres
Publié: (2015)

Real Life Experience of Dexamethasone Implant in Refractory Diabetic Macular Oedema
par: Karttunen T, et autres
Publié: (2019)

Outcomes of Epiretinal Membrane Removal Utilizing Triamcinolone Acetonide Visualization and Internal Limiting Membrane Forceps
par: Asahi MG, et autres
Publié: (2020)

Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review
par: Wallsh J, et autres
Publié: (2020)

Transdermal permeability of triamcinolone acetonide lipid nanoparticles
par: Qin ZM, et autres
Publié: (2019)

Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
par: Lam WC, et autres
Publié: (2015)

Long-Term Outcomes of Macular Hole Repair with Triamcinolone Acetonide Visualization
par: Wallsh J, et autres
Publié: (2021)

Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion
par: Michalska-Małecka K, et autres
Publié: (2016)

The relative effects of Ca and Mg ions on MSC osteogenesis in the surface modification of microrough Ti implants
par: Park JW, et autres
Publié: (2019)